Stakeholder perspectives on a risk-benefit framework for genetic testing.

Abstract excerpt

A key to accelerating the appropriate integration of genomic applications into healthcare in the coming decades will be the ability to assess the tradeoffs between clinical benefits and clinical risks of genetic tests in a timely manner. Several factors limit the ability of stakeholders to achieve this objective, including the lack of direct evidence, the lack of a framework to quantitatively assess risk and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Testing
• Share to Genomics
• Share to Genotype